MODEX Trademark

Trademark Overview


On Thursday, February 9, 2023, a trademark application was filed for MODEX with the United States Patent and Trademark Office. The USPTO has given the MODEX trademark a serial number of 97788161. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Tuesday, December 3, 2024. This trademark is owned by ModeX Therapeutics, Inc.. The MODEX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for cancer and infectious diseases

Medical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy
modex

General Information


Serial Number97788161
Word MarkMODEX
Filing DateThursday, February 9, 2023
Status651 - SUSPENSION INQUIRY - MAILED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for cancer and infectious diseases
Goods and ServicesMedical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModeX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Monday, February 13, 2023NEW APPLICATION ENTERED
Tuesday, February 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Wednesday, November 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2024SUSPENSION LETTER WRITTEN
Friday, January 19, 2024LETTER OF SUSPENSION E-MAILED
Friday, January 19, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 3, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, December 3, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 3, 2024INQUIRY TO SUSPENSION E-MAILED